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Abstract 
Background: Diastolic dysfunction is a major cause of morbidity in obese individuals. We aimed to assess the ability 
of magnetic resonance imaging (MRI) derived left atrial (LA) strain to detect early diastolic dysfunction in individuals 
with obesity and type 2 diabetes, and to explore the association between cardiac adipose tissue and LA function.
Methods: Twenty patients with obesity and T2D (55 ± 8 years) and nineteen healthy controls (48 ± 13 years) were 
imaged using cine steady state free precession and 2-point Dixon cardiovascular magnetic resonance. LA function 
was quantified using a feature tracking technique with definition of phasic longitudinal strain and strain rates, as well 
as radial motion fraction and radial velocities.
Results: Systolic left ventricular size and function were similar between the obesity and type 2 diabetes and control 
groups by MRI. All patients except four had normal diastolic assessment by echocardiography. In contrast, measures 
of LA function using magnetic resonance feature tracking were uniformly altered in the obesity and type 2 diabe-
tes group only. Although there was no significant difference in intra-myocardial fat fraction, Dixon 3D epicardial 
fat volume(EFV) was significantly elevated in the obesity and type 2 diabetes versus control group (135 ± 31 vs. 
90 ± 30 mL/m2, p < 0.001). There were significant correlations between LA functional indices and both BMI and EFV 
(p ≤ 0.007).
Conclusions: LA MRI-strain may be a sensitive tool for the detection of early diastolic dysfunction in individuals with 
obesity and type 2 diabetes and correlated with BMI and epicardial fat supporting a possible association between 
adiposity and LA strain.
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Background
Obesity and diabetes are strong risk factors for heart 
failure with preserved ejection fraction (HFpEF), a clini-
cal syndrome that affects nearly half of patients with 
symptoms of heart failure [1]. Diastolic dysfunction is an 
asymptomatic condition leading to heart failure and is 
traditionally assessed by echocardiography. However, a 
reliable and sensitive method for the early identification 
of diastolic dysfunction is currently lacking [2–4]. The 
earliest manifestations of diastolic dysfunction are typi-
cally evident in altered left atrial dynamics or pulmonary 
inflow patterns [5]. The features represent are good target 
for early diastolic dysfunction detection and improved 
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methods for capturing these physiological signs would 
therefore be of great clinical and scientific interest.
Obesity and type 2 diabetes mellitus (ObT2D) com-
monly co-exist and together they contribute to a wide 
range of metabolic complications; importantly, they are 
increasingly recognised to be major contributors to the 
global burden of cardiac disease. The paucity of reli-
able early, non-invasive detection of diastolic changes on 
ObT2D population is therefore a key limitation of our 
current clinical and research capacity.
The changes associated with the mid and late stages 
of diastolic dysfunction in individuals with obesity and 
T2D include a complex spectrum of adipose infiltra-
tion (both intra-myocardial and epicardial), fibrosis 
and electrophysiological alterations. Of these factors, 
intra-myocardial and epicardial fatty changes have 
received considerable attention. However, the relation-
ship between cardiac fat and early dysfunction remains 
poorly understood. This deficit is largely attributable to 
the difficulties in detecting very early alterations in car-
diac function.
LA functional and volumetric changes are amongst 
the first imaging changes seen in ObT2D, and therefore 
may be a useful marker of early disease [6–8]. Recent 
data shows that diabetes is an independent risk factor 
predictive of LA enlargement and dysfunction. Data has 
also linked epicardial fat to LA and ventricular func-
tional changes [9], and to increased LA volume [10, 11]. 
A highly powered analysis using a Framingham cohort 
demonstrated that this association is independent of 
other measures of adiposity in men [11].
Although echocardiography is the generally accepted 
gold standard for measurement of atrial function and 
other diastolic functional or structural changes, in the 
setting of obesity the practical difficulties of imaging 
obese patients make routine acquisitions problematic. 
Cardiovascular magnetic resonance (CMR) may present 
a good alternative for reproducible, accurate and sensi-
tive quantification of LA function. The recent develop-
ment of feature tracking algorithms that can be applied 
in a semi-automated manner to CMR data permits myo-
cardial strain measurements to be obtained from cine 
functional images [12–14]. CMR simultaneously offers a 
convenient and accurate way to quantify pericardial fat 
using anatomical images, or with specific fat quantifica-
tion techniques such as Dixon [15].
In this study, we applied a novel MRI method for meas-
uring atrial strain to detect subclinical evidence for dias-
tolic dysfunction in a cohort of obese individuals with 
type 2 diabetes and no clinical evidence of heart failure. 
As a secondary aim, we assessed the association between 




The first 20 consecutive patients from the study entitled 
“The combined Effect of Liraglutide and Sleeve Gastrec-
tomy on Metabolic, Cardiac, Neurological and Sleep 
Function in Obese Diabetes” (LIRASLEEVE; mean age 
55 ± 8 years; 40% female) with a diagnosis of obesity and 
type 2 diabetes mellitus were recruited via the Depart-
ment of Endocrinology, Diabetes and Metabolism at 
Royal North Shore Hospital, Australia. Inclusion criteria 
included BMI >30 kg/m2 and known T2D (HbA1c ranged 
from 7 to 10% at study entry). Subjects were excluded if 
there was a contraindication to MRI or weight in excess 
of 150  kg (MRI table limit). Nineteen age and gender 
matched controls (48  ±  13  years; 47% female) with no 
history of cardiac disease were recruited. The local ethics 
committee approved the study and all patients provided 
written consent.
Cardiovascular magnetic resonance imaging
CMR data were acquired using a 1.5T Siemens Avanto 
scanner at North Shore Private Radiology, St Leonards, 
Australia. Cardiac volumes and left ventricle (LV) mass 
were quantified using 2-chamber (LVLA), 4-chamber 
(4CH), 3-chamber (LVOT) views and a short axis stack 
of cine SSFP images (TE: 1.5 ms, TR: 3.4 ms, 20 phases; 
flip angle: 45°, acquisition; FOV: 35  cm, slice thick-
ness: 8 mm). 2-point Dixon data was also acquired (TR 
6.7  ms, resolution: 1.2  mm, slice thickness: 4  mm, TE2: 
2.4, 4.8 ms). One patient and one healthy volunteer were 
excluded from the analysis as the Dixon images were not 
available.
Ventricular functional analysis
Region of interest analysis was performed using the Seg-
ment software (Medviso, Lund, Sweden) [16]. LV end-
diastolic (EDV) and end-systolic volumes (ESV), indexed 
LV mass, LV stroke volume (SV) and LV ejection fraction 
(LVEF) were obtained from the short axis stack by manu-
ally contouring end-diastolic and end-systolic endocar-
dial borders and end-diastolic epicardial borders from 
the base to the apex.
Left atrial strain and volume analysis
The analysis and feature tracking algorithm has pre-
viously been described in details [14]. It was quanti-
fied on LVLA, 4CH, and LVOT views and averaged for 
a global analysis. After endocardial contour tracking, 
longitudinal strain was defined as the temporal varia-
tion of the length of the contour, and was calculated as 
[Slt = (Lt − Lo)/Lo], where Lo is the initial length of the 
contour and Lt is the length at time t. Radial motion frac-
tion corresponded to the radial relative displacement of 
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the considered segment towards the LA centre of mass, 
[Mr =  (Mt −  Mo)/Mo], where Mo is the initial radius, 
and Mt, the radius at time t.
Figure  1 summarises the LA strain functional meth-
odology and analysis. Briefly, parameters are classified 
according to reservoir (R), conduit (C) or atrial contrac-
tion (A) phases. LA phasic measurements were made for 
longitudinal strain (Sl) and radial motion fraction (Mr), 
where the phase is denoted as a suffix (SlR, SlC, SlA), (MrR, 
MrC, MrA) respectively. Longitudinal strain rates (SRlS′, 
SRlE′, SRlA′) and radial relative velocities (VrS′, VrE′, VrA′) 
were computed, as the time derivatives of longitudinal 
and radial indices, for the three atrial functional phases: 
reservoir (S′), conduit (E′) and LA contraction (A′).
To further investigate the radial motion fraction 
modifications in term of LV related and LA standalone 
motions, this parameter was decomposed into two 
orthogonal components relative to the centre of the 
mitral valve (MV). The first, in the direction of the MV, 
was termed centric (cMr) and the other, normal to this 
direction (termed MV perpendicular: pMr, see Fig.  1). 
These two components describe the motion that broadly 
results from the LV translational movement (MV perpen-
dicular radial motion fraction, pMr) and the LA related 
movements (MV centric radial motion fraction, cMr).
Epicardial and intra‑myocardial fat quantification
Fat measurement was performed following segmentation 
of the Dixon data into fat and water images (Fig. 2) [15]. 
Intra-myocardial fat was quantified using a hand-drawn 
ROI covering the myocardial septum in the 4CH view, 
with care taken to avoid partial volume effects (Fig. 2a). 
Epicardial fat was quantified blindly between patients 
and controls by segmenting cardiac volumes and Dixon 
Fig. 1 Illustration of the methodology for LA function analysis. a, b Left atrial contours from a 4-chamber view and longitudinal strain and strain 
rate related curves of a subject from the Obese-Type 2 diabetes (ObT2D) group. Ro example of a radius used for the computation of the radial 
motion fraction. Decomposition of the radial motion fraction into MV centric (cMr, towards the mitral valve center) and MV corrected perpendicular 
(pMr, MV corrected perpendicular radial motion fraction) components. c, d SlR reservoir longitudinal strain, SlC conduit longitudinal strain and SlA 
La contraction longitudinal strain, SRLS′ reservoir longitudinal strain rate, SRlE′ conduit longitudinal strain rate and SRlA′ LA contraction longitudinal 
strain rate
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fat images using Kmeans clustering by a semiautomatic 
program implemented in python and Paraview (Fig.  2). 
The volumes of the cluster corresponding to the adipose 
tissue were then calculated to define an absolute fat vol-
ume, which is then divided by the whole heart volume to 
obtain a 3D MRI Dixon adipose fraction. In order to nor-
malize the volume of epicardial fat present by body size, 
absolute fat volume was indexed to BSA.
Echocardiography
Diastolic function was assessed by echocardiography in 
patients using the American Society of Echocardiogra-
phy guidelines [17]. The following parameters were col-
lected—mitral inflow E and A waves, E′ lateral velocity 
of the MV annulus measured by tissue Doppler imag-
ing, and aortic peak velocity and flow. One patient was 
excluded from the echocardiography analysis due to 
inadequate images secondary to the technical difficulty of 
the scan.
Statistical analysis
Statistical analyses were carried out using SPSS Version 
22 (IBM, Armonk, NY). All continuous variables are 
expressed as mean ±  standard deviation (SD). Normal-
ity was checked using the Shapiro–Wilk test. Differences 
between groups were considered significant for p < 0.05. 
Intra-observer was assessed using intra class correla-
tion coefficient (ICC). Groups were compared using the 
independent-samples t test for normally distributed con-




Table  1-A summarises the demographics, global car-
diac functional measures by CMR, and echocardio-
graphic measurements in the ObT2D and control groups. 
There were no significant differences in age or gen-
der between the ObT2D and control group. The aver-
age BMI in the ObT2D group classed them as morbidly 
obese (39 ± 3 kg/m2, range: 30–51 kg/m2); all individu-
als within the control group had a BMI  <  30  kg/m2. At 
study entry, the ObT2D group had an average duration of 
T2Dof 11.4 ± 6.2 years and a mean HbA1c of 8.4 ± 1.1%.
LV functional assessment
Echocardiographic diastolic data for the ObT2D group 
are presented in Table  1-B. No echocardiographic 
data were obtained for the control group. Echocar-
diographic measures of diastolic function were within 
the normal standardised range in patients except E/E′ 
ratio, which was elevated at  >8 in four subjects within 
the ObT2D group, and two greater than 15 (E/E′ range 
8.3–17.1). Small significant differences in indexed LV 
ESV (p =  0.02) and mean mid myocardial LV thickness 
(p =  0.003) were found in the ObT2D group compared 
to control (Table 1-C) as compared to healthy volunteers.
Left atrial size and strain measurements
Table 2 summarizes the MRI-derived LA volumetric and 
functional strain measurements. All MRI atrial volumet-
ric measures were within the normal range for both the 
ObT2D and control groups. There were no significant 
Fig. 2 2D intra-myocardial fat fraction (a), and 3D Dixon adipose tissue quantification (b), fat (a) images from DIXON sequence. K-means segmenta-
tion of the heart and detection of the epicardial fat (a, b)
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differences in LA volumes or LVEF, even after indexing to 
BSA between the ObT2D and control groups.
LA longitudinal strain (SlR), longitudinal strain rate 
(SRlS′), and radial motion fraction (MrR), were slightly 
reduced during reservoir phase in the ObT2D group com-
pared to control and slightly increased for the atrial con-
traction phase (SlA, SRlA′,MrA). Both longitudinal strain 
and radial motion fraction were significantly reduced in the 
conduit phase (ObT2D vs. control, p =  0.04). Expressed 
as an E′/A′ ratio, there was a 28.5% reduction in the lon-
gitudinal strain rate ratio (SRlE′/SRlA′, ObT2D vs. control, 
p =  0.01). When radial motion was expressed as a rela-
tive velocity, the group difference was accentuated, with a 
38.2% reduction in the VrE′/VrA′ ratio (ObT2D vs. control, 
p < 0.001). The radial motion ratio was also increased by 
12.7% (MrA/MrR, ObT2D vs. control, p = 0.020).
In the ObT2D group, the MV corrected perpendicular 
component of the radial motion was decreased by 20% 
during the reservoir phase and by 33.6% in the conduit 
phase (ObT2D vs. control, p = 0.04 and p = 0.09 respec-
tively). During the atrial relaxation (reservoir) and con-
traction phases, the MV centric radial components were 
higher in the ObT2D group compared to control (MV 
centric radial motion fraction in reservoir cMrR, p = ns; 
in LA contraction cMrA: p  =  0.005). The increased 
cMrA in the ObT2D group corresponded to a magnitude 
change of +28% relative to controls (20 vs. 26% in the 
MV centric radial plane defined in Fig. 1).
Table 1 Demographic, clinical, echocardiographic and cardiovascular MRI measurements
A. subject characteristics
B. echocardiographic LV function assessment in the ObT2D group
C. MRI LV function assessment in the control and ObT2D groups




Healthy volunteers ObT2D HV/ObT2D
(n = 19) (n = 20) p value
A. subject characteristics
 Age (years) 47.5 ± 12.5 54.6 ± 7.8
 Women (%) 45 40.0
 HbA1c (%) – 8.5 ± 1.0
 Duration of diabetes (years) – 11.3 ± 6.1
 Proportion of patients taking lipid-lowering therapy (%) – 100.0
 Proportion of patients taking anti-hypertensives (%) – 80.0
 History of CVD (%) – 30.0
 Body surface area (m2) 1.9 ± 0.2 2.2 ± 0.2 **
 Body mass index (kg/m2) 24.8 ± 2.6 39.7 ± 5.8 ***
B. echocardiographic parameters in ObT2D patients
 Age (years) 54.6 ± 7.8 40–60
 Mitral peak E velocity (m/s) 0.75 ± 0.24 0.75 ± 0.17
 Mitral peak A velocity (m/s) 0.74 ± 0.18 0.62 ± 0.15
 E/A ratio 0.99 ± 0.28 1.24 ± 0.39
 E′ Lateral myocardium velocity (cm/s) 10.50 ± 2.4 12.5 ± 3.0
 E/E′ ratio 7.6 ± 3.7 6.3 ± 2.2
 Aortic valve peak velocity (m/s) 1.43 ± 0.57
C. MRI LV function parameters
 Indexed LV mass (g/m2) 75.1 ± 14.9 80.8 ± 16.1
 LV EDV (mL) 122.8 ± 24.0 130.8 ± 34.0
 LV ESV (mL) 49.4 ± 13.4 44.8 ± 18.6
 Indexed LV EDV (mL/m2) 63.8 ± 11.4 58.9 ± 13.4
 Indexed LV ESV (mL/m2) 25.7 ± 7.1 20.1 ± 7.3 *
 LV EF (%) 60.9 ± 7.4 66.1 ± 8.8
 Mean Mid. LV thickness (mm) 11.1 ± 2.0 12.9 ± 1.6 **
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Intra‑myocardial and epicardial fat measurements
Intra-observer assessment resulted in an intra-class cor-
relation coefficient of 0.95. Slight differences in intra-
myocardial fat fraction were present between groups 
(ObT2D vs. control, 7.9 ± 3.7% vs. 6.0 ± 1.5%, p = 0.051; 
Table 3). In the ObT2D group, the epicardial fat measure-
ment was increased by 69% for absolute volume and by 
50% for indexed volume (ObT2D vs. control, 176.9 ± 76.6 
vs. 298.9 ± 83.4 mL, p < 0.001 for absolute volume and 
89.7 ± 29.6 vs. 134.6 ± 30.8 mL/m2, p < 0.001 for indexed 
volume). Following correction for BMI, these differences 
were attenuated but remained significant (p = 0.001).
Correlations between left atrial function and measures 
of ObT2D
Figure 3a–c illustrates the relationship between BSA and 
longitudinal strains and motion fractions (SlR, MrR and 
MrC, Panel a), VrE′/VrA′ and BMI (panel b), and VrE′/VrA′ 
and epicardial fat volume indexed to BSA (panel c). These 
demonstrated tight clustering of the VrE′/VrA′ values in 
the ObT2D group, with all of the subjects falling into the 
lowest two quartiles of VrE′/VrA′ (as defined using the 
normal cohort), and 70% within the lowest quartile of the 
normal range. There was no overlap in BMI and almost 
no overlap in epicardial fat. Significantly, all subjects with 
a BMI over 30 kg/m2 had low values of VrE′/VrA′– below 
or near 1 standard deviation from the control group 
average value. Other significant associations between 
Dixon 3D epicardial fat fraction and functional LA indi-
ces are presented in Fig. 3d–f (SRlE/SRlA, VrE/VrA, MrA, 
MrA/MrR). Correlation coefficients between functional 
indexes and BSA or Dixon 3D epicardial fat fraction are 
reported Table 4.
By univariate analysis, intra-myocardial fat was cor-
related to VrE′/VrA′ in the control group (r  =  −0.602; 
p  =  0.006). No other significant correlations were seen 
in either controls or in the ObT2D group (correlation 
VrE′/VrA′ with intra-myocardial fat in patients r =  0.18; 
p = ns). Figure 3 highlights that there is a lack of dynamic 
range for VrE′/VrA′ in the ObT2D group, with values 
tightly clustered together. Therefore, linear correlation 
between BMI or epicardial fat was not performed to fur-
ther analyse for any linear relationship. The ObT2D and 
control groups clearly did not form a normal distribution 
hence a pooled analysis was not performed.
The correlations between MV centric radial motion 
fraction and adipose tissue quantifications and patient 
biology were highly significant between cMrR and BSA 
(r  =  −0.49, p  =  0.002) and between cMrR and BMI 
(r  =  −0.44, p  =  0.005). Significant correlations were 
also found for indexed and non-indexed Dixon 3D epi-
cardial fat volumes with cMrR (r = −0.33, p = 0.04 and 
r = −0.41, p =  0.01, respectively) and pMrA (r =  0.46, 
p = 0.004 and r = 0.37, p = 0.02). No significant correla-
tions were present between atrial parameters and dura-
tion of diabetes or HbA1c.
Discussion
Our data demonstrates that MRI-derived LA strain may 
be sensitive to early diastolic dysfunction. Our cohort 
of patients with obesity and T2D had an almost normal 
Table 2 Left atrium volumes and  functional parameters 
derived from MRI data






(n = 19) (n = 20) p value
LA EDV (mL) 87.1 ± 24.7 95.8 ± 22.3
LA ESV (mL) 37.4 ± 14.7 40.5 ± 12.8
Indexed LA EDV (mL/m2) 44.7 ± 9.8 43.3 ± 9.3
Indexed LA ESV (mL/m2) 19.1 ± 6.1 18.2 ± 5.2
LA EF (%) 57.7 ± 6.1 58.0 ± 7.9
Longitudinal strain (%)
 SlR 33.2 ± 6.8 29.4 ± 8.4
 SlC 16.5 ± 4.8 13.1 ± 5.0 *
 SlA 16.7 ± 3.9 16.8 ± 4.8
 SlA/SLR 0.5 ± 0.1 0.6 ± 0.1
Longitudinal strain rate (%/s)
 SRlS′ 1.4 ± 0.3 1.4 ± 0.4
 SRlE′ −1.5 ± 0.4 −1.2 ± 0.6
 SRlA′ −1.4 ± 0.4 −1.5 ± 0.5
 SRlE′/SRlA′ 1.2 ± 0.5 0.9 ± 0.3 *
Radial motion fraction (%)
 MrR 35.1 ± 6.7 31.5 ± 9.1
 MrC 17.2 ± 4.7 13.6 ± 5.9 *
 MrA 17.9 ± 4.3 18.2 ± 4.3
 MrA/MrR 0.5 ± 0.1 0.6 ± 0.1 *
Radial relative velocity (%/s)
 VrS′ 1.4 ± 0.3 1.5 ± 0.6
 VrE′ −1.6 ± 0.5 −1.3 ± 0.6
 VrA′ −1.5 ± 0.5 −1.8 ± 0.6
 VrE′/VrA′ 1.2 ± 0.5 0.7 ± 0.2 ***
Decomposition of the radial motion fraction (%)
 MV centric cMrR 34.3 ± 9.6 37.2 ± 10.6
 MV centric cMrC 14.0 ± 5.7 11.3 ± 5.7
 MV centric cMrA 20.3 ± 5.6 26.0 ± 6.3 **
 MV corrected perpen-
dicular pMrR
53.3 ± 17.8 42.5 ± 12.6 *
 MV corrected perpen-
dicular pMrC
21.0 ± 15.2 14.0 ± 9.5
 MV corrected perpen-
dicular pMrA
32.3 ± 10.7 28.6 ± 10.7
Page 7 of 10Evin et al. Cardiovasc Diabetol  (2016) 15:164 
echocardiogram and non-enlarged LA volumes by stand-
ard imaging techniques [17]. Furthermore, our results 
show that LA strain is strongly correlated with BMI and 
epicardial fat supporting an association between adipos-
ity and LA strain. If LA strain measures are validated, the 
ability to reliably detect early changes likely to be a pre-
cursor to clinically apparent disease may have important 
applications as both a clinical and research tool. Moreo-
ver, identification of individuals at risk for progression of 
the early diastolic dysfunction in ObT2Dmay enable (i) a 
more comprehensive characterisation of the patho physi-
ology of early LA functional alteration in diastolic func-
tion, and (ii) testing of novel disease modifying strategies.
Alterations of LA function in the ObT2D population 
are considered to be secondary to pressure overload 
and are associated with poorer LV systolic function and 
higher LV mass [8]. Consistent with this, our results 
demonstrated an alteration of the LA function in indi-
viduals with obesity and T2D, as expressed by the ratio 
between conduit to LA contraction phase (E′/A′) and 
the LA contraction to reservoir phases. Both longitudi-
nal strain rates SRlE′/SRlA′ and relative velocity VrE′/VrA′ 
ratios were significantly altered in the obese and diabetic 
group compared to matched controls, consistent with 
early stage diastolic dysfunction. Our data demonstrated 
a diminution of the conduit phase of LA function. A pos-
sible explanation for this finding could be elevated LV 
pressure, which is well described to be an early change 
in diastolic dysfunction. Coronary flow reserve has also 
been associated with LV filling pressure [18] in ObT2D 
which suggest a more sophisticated pathway of diastolic 
dysfunction. Additionally, the longitudinal (SRlE′/SRlA′) 
Table 3 Fat measurements by MRI and echocardiography in healthy volunteers and obese patients
Results are expressed as mean ± SD
*** p < 0.001
Healthy volunteers ObT2D HV/ObT2D
(n = 19) (n = 20) p value
Intra-myocardium dixon fat fraction (%) 7.9 ± 3.7 6.0 ± 1.5
Dixon 3D epicardial fat volume (mL) 176.4 ± 68.6 273.8 ± 64.0 ***
Indexed dixon 3D epicardial fat volume (mL/m2) 89.7 ± 25.2 123.6 ± 23.4 ***
Dixon 3D epicardial fat fraction (%) 21.0 ± 4.0 28.4 ± 5.5 ***
Fig. 3 Correlations between BSA and LA functional indices in the control and ObT2D groups (a). VrE′/VrA′ related to BMI (b) and indexed adipose 
tissue volume (c). Correlations between LA functional indices and 3D Dixon cardiac fat fraction: longitudinal strain rates and radial relative velocities 
ratios (d), and radial motion fraction (e) and with radial motion fraction ratio (f)
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and radial (VrE′/VrA′) ratios depicted the change in the 
LA wall deformation, the passive conduit phase relative 
to the active phase of the LA. When radial motion was 
decomposed into cMr and pMr parts, the amplification 
of MV centric motion fraction during the LA contrac-
tion phase in the ObT2D group was consistent with the 
anticipated response of an early decrease in ventricu-
lar compliance impairing LV early filling. The observed 
reduction of reservoir MV corrected perpendicular 
motion fraction may related to LV contraction altera-
tions as reported by Mochizuki et  al. [19]. An increase 
in the functional parameters of LA contraction has been 
previously described in association with mild diastolic 
dysfunction, and has been proposed as a method of dif-
ferentiating changes resulting from LV compliance as 
opposed to LV hypertrophy [8, 20].
An association between BMI and LA function has been 
previously described [21–23]. In our study, the use of 
MRI enabled the quantification of LA function, LV intra-
myocardial and epicardial fat during the same examina-
tion. We demonstrated a clear relationship between LA 
relative velocity ratios and both BMI and epicardial fat 
volume. When the ObT2D and control groups were con-
sidered separately, there was no significant linear rela-
tionship between BMI or epicardial fat and LA function, 
perhaps due to our small sample size. This may suggest 
that LA functional alterations seen in the ObT2D group 
may occur over a certain threshold of epicardial adipose 
tissue volume or BMI. However, further data are required 
to test this hypothesis.
There are several proposed mechanisms by which the 
tissue alterations in obesity may influence the properties 
or mechanical load experienced by the LA. These include 
increased ventricular stiffness, inflammation mediated 
by adipokines, direct lipotoxicity or a metabolic effect 
mediated by insulin resistance [9]. Diastolic dysfunction 
has been previously shown to correlate with duration of 
diabetes, HbA1c and obesity [24]. Previous reports of 
correlations between strains and BSA or BMI were lim-
ited to ventricle [25] and detailed LV strain contraction 
analysis highlight the rule of glycemic control [26]. In our 
study, we did not find an association between LA strain 
and duration of diabetes or HbA1c, possibly due to the 
early stage of diastolic dysfunction detected. Prior echo-
cardiographic data support a primary atrial myopathy in 
diabetes [27, 28]. Our study demonstrated alterations of 
conduit longitudinal strain and motion fraction, changes 
which are supportive of primary alterations of LV relaxa-
tion associated with mild diastolic dysfunction [29]. The 
strong correlation between MV centric motion fraction 
and BMI/epicardial fat might suggest MV centric motion 
fraction during LA contraction phase as a useful earlier 
predictor of diastolic dysfunction in the setting of obesity 
and T2D.
Our data demonstrated no significant differences in 
intra-myocardial Dixon fat between the ObT2D and 
control groups. A previous study reported a correlation 
between altered LV intra-myocardial fat fraction and LA 
function [10]. Our MRI data from subjects with early 
functional LA changes is a novel finding suggesting that 
intra-myocardial LV changes may not be a primary event 
driving very early dysfunction. The Dixon technique is 
only able to measure intra-myocardial fat quantity. It 
is insensitive to other myocardial tissue organisational 
alterations occurring in obesity and T2D. Further data 
regarding other ultra-structural analysis (e.g. from dif-
fusion tensor imaging [30], T1 mapping [31], biochemi-
cal changes [32], or even electrophysiology [33]) may be 
helpful in extending the characterisation of LV structural 
changes in early diastolic dysfunction.
MRI is an attractive alternative to the routine use of 
echocardiography as it overcomes the practical problems 
of image attainment in obese patients and simultane-
ously characterises LA and LV functions as well as car-
diac structure. The determination of cardiac fat volume 
Table 4 Correlations between  functional indexes 




Body surface area (m2) Dixon 3D epicardial 
fat fraction (%)
r p r p
Longitudinal strain (%)
 SlR −0.561*** <0.001 −0.079 0.636
 SlE −0.456** 0.004 −0.141 0.399
 SlA −0.390* 0.014 0.090 0.591
 SlA/SlR −0.373* 0.019 −0.335* 0.040
Longitudinal strain rate (%/s)
 SRlS′ 0.067 0.687 0.128 0.443
 SRlE′ −0.302 0.062 0.043 0.798
 SRlA′ 0.394* 0.013 0.096 0.566
 SRlE′/SRlA′ −0.006 0.971 −0.269 0.103
Radial motion fraction (%)
 MrR −0.570*** <0.001 −0.041 0.805
 MrE −0.576*** <0.001 −0.143 0.390
 MrA −0.284 0.080 0.153 0.359
 MrA/MrR 0.278 0.087 0.244 0.140
Radial relative velocity (%/s)
 VrS′ −0.064 0.698 0.252 0.127
 VrE′ 0.437** 0.005 0.071 0.674
 VrA′ −0.024 0.884 −0.355* 0.029
 VrE′/VrA′ −0.413** 0.009 −0.435** 0.006
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by Dixon images has been previously reported [34]. How-
ever, our study is the first to use MRI to measure cardiac 
size, volume atrial strain and fat in one examination. This 
approach is likely to help to understand the pathogene-
sis of diastolic dysfunction in obesity and diabetes, and 
would enable testing of novel early therapeutic options in 
these patients. Further studies are needed to understand 
the different components of cardiac functional and struc-
tural modification in the setting of obesity and diabetes in 
order to explore possible therapeutic routes for reversal.
This study has several limitations, including the rela-
tively small sample size, slightly age range difference 
between patients and healthy volunteers, and uniform 
diagnosis of obesity and diabetes, which did not permit 
deconvolution of the contributions of these conditions. 
Additional studies are required on the decomposition of 
radial motion into centric and perpendicular motions. 
Our clinical evaluation of the control subjects was also 
limited and measured blood pressures were not available, 
a clinical diagnosis of any cardiovascular disease includ-
ing hypertension was excluded for all controls. The qual-
ity of the myocardial characterisation could be improved 
with the addition of T1 mapping or magnetic resonance 
spectroscopy data. In order to explore the nature of the 
early changes occurring in obesity and T2D, prospective 
studies are needed that include longitudinal imaging time 
points combined with objective clinical and metabolic 
measures (e.g. glucose tolerance test) of the progres-
sive metabolic disorders over time. Although the control 
echocardiographic data was not available in this study, 
from a methodological perspective, it would be useful to 
directly compare diastolic assessment by echocardiogra-
phy between the controls and ObT2D groups.
Conclusion
MRI-derived strain measurements may be a useful tool to 
detect early abnormal LA function. Our cohort of patients 
with obesity and T2D had near normal echocardiograms 
and MRI-derived LV systolic function and volumetric 
measures of the LA and LV, and we demonstrated clear 
reductions in the conduit to LA contraction ratios (E/A) 
for longitudinal strain rate and radial motion fraction. 
Importantly these atrial measures correlated to both epi-
cardial fat and to BMI. Further work in larger cohorts with 
a greater dynamic range of these parameters is required to 
understand the full implications of these findings.
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